Can the use of low-dose dopamine for treatment of acute renal failure be justified?

Postgraduate Medical Journal

Volumn 75, Issue 883, 1999, Pages 269-274

  Burton, Christopher J ^a   Tomson, Charles R V ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Dopamine; Renal failure

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; DOPAMINE;

ACUTE KIDNEY FAILURE; DRUG EFFICACY; HUMAN; MALARIA; PHYSIOLOGY; REVIEW; VASODILATATION;

EID: 0032893484     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.75.883.269     Document Type: Review

References (68)

1. McNay JL, McDonald RH, Goldberg LI. Direct renal vasodilatation produced by dopamine in the dog. Circ Res 1965;16:510-7.
2. McDonald RH, Goldberg LI, McNay JL, Tuttle EP. Effects of dopamine in man: augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. J Clin Invest 1964;43: 1116-24.
3. Goldberg LJ. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev 1972;24:1-29.
4. Talley RC, Forland M, Beller B. Reversal of acute renal failure with a combination of intravenous dopamine and diuretics (abstract). Clin Res 1970;18:518.
5. Thompson BT, Cockrill BA. Renal dose dopamine: a siren song? Lancet 1994;344:7-8.
6. Cuthbertson BH, Noble DW. Dopamine in oliguria. BMJ 1997;314:690-1.
7. Denton MD, Chertow GM, Brady HR. Renal dose dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials. Kidney Int 1996;50:4-14.
8. Horwitz D, Fox SM, Goldberg LI. Effects of dopamine in man. Circ Res 1962;10:237-43.
9. Eble JN. A proposed mechanism for the depressor effect of dopamine in the anesthetized dog. J Pharmacol Exp Ther 1964;145:64-70.
10. Lee MR. Dopamine and the kidney: ten years on. Clin Sci 1993;84:357-75.
11. Brodde O-E. Affinities of dopamine agonists and antagonists for peripheral dopamine receptors. In: Hieble JP, ed, Cardiovascular function of peripheral dopamine receptors. New York: Marcel Dekker, 1989: pp27-72.
12. Dasta J, Kirby M. Pharmacology and therapeutic use of low-dose dopamine. Pharmacotherapy 1986;6:304.
13. Hsieh YY, Goldberg LJ. Hemodynamic consequences of administration of phentolamine or nitroprusside with dopamine in the dog. J Cardiovasc Pharmacol 1979;1:379-88.
14. Edwards RM. Comparison of the effects of fenoldopam, SKF R-87516, and dopamine on renal arterioles in vitro. Eur J Pharmacol 1986;126:167-70.
15. Ramdohr B, Biamino G, Schroder R. Vergleichende Untersuchungen uber die wirkung von dopamin und orceprenalin am gesunden menschen: muskeldurchblutung, nierendurchblutung, nierenfunction. Klin Wochenschr 1972; 50:149-57.
16. +-ATPase activity in proximal tubules from rat kidney. Acta Physiol Scand 1988;132: 441-3.
17. 1 regulated sodium transport in renal cortical brush border membrane vesicles. Am J Hypertens 1990;3:42-57S.
18. Ratcliffe PJ. Pathophysiology of acute renal failure. In: Cameron JS, Davison AM, Grunfeld JP, Kerr D, Ritz E, eds. Oxford textbook of clinical nephrology. Oxford: Oxford University Press, 1998; pp 1531-56.
19. Oken DE. Hemodynamic basis for human acute renal failure (vasomotor nephropathy). Am J Med 1984;76:702-10
20. Iaina A, Solomon S, Gavendo S, Eliahou HE. Reduction in severity of acute renal failure (ARF) in rats by dopamine. Biomedicine 1977; 27:137-9.
21. Goldfarb D, Iaina A, Serban I, Gavendo S, Eliahou HE. Dopamine in the early recovery phase of acute ischemic renal failure in rats. Isr J Med Sci 1981;17:1069-71
22. Pollock DM, Opgenorth TJ. Beneficial effect of the atrial natriuretic factor analog A68828 in post ischemic acute renal failure. J Pharmacol Exp Ther 1990;255:1166-9.
23. Atanasova I, Girchev R, Dimitrov D, et al. Atrial natriuretic peptide and dopamine in a dog model of acute renal ischemia. Acta Physiol Hung 1994;82:75-85.
24. Stein JH, Gottschall J, Osgood RW, Ferris TF. Pathophysiology of a nephrotoxic model of acute renal failure. Kidney Int 1975;8:27-41.
25. Drieman JC, van Kan FJPM, Thijssen HHW, et al. Regional haemodynamic effects of dopamine and its prodrugs L-dopa and gludopa in the rat and in the glycerol-treated rat as a model for acute renal failure. Br J Pharmacol 1994;111: 1117-22.
26. Neiberger RE, Passmore JC. Effects of dopamine on canine intrarenal blood flow distribution during hemorrhage. Kidney Int 1979;15:219-26.
27. Pålsson J, Ricksten SE, Houltz E, Lundin S. Effects of dopamine, dopexamine and dobutamine on renal excretory function during experimental sepsis in conscious rats. Acta Anaesthesiol Scand 1997;41:392-8.
28. Gómez-Garre DN, López-Farré A, Eleno N, López-Novoa JM. Comparative effects of dopexamine and dopamine on glycerol induced acute renal failure in rats. Renal Failure 1996;18: 59-68.
29. Lindner A, Cutler RE, Goodman WG. Synergism of dopamine plus furosemide in preventing acute renal failure in the dog. Kidney Int 1979;16:158-66.
30. Hammond JJ, Overturf ML, Kirkendall WM. Preliminary observations concerning the effect of dopamine on uranyl nitrate induced renal failure. Experientia 1979;35:1630-1.
31. Bomzon L, Wilton PB, Kew MC. The effect of dopamine on renal cortical blood flow in baboons with experimentally induced obstructive jaundice. Israel J Med Sci 1978;14:1069-72.
32. Baldwin L, Henderson A, Hickman P. Effect of postoperative dopamine on renal function after elective major vascular surgery. Ann Int Med 1994;120:744-7.
33. Paul MD, Mazer CD, Byrick RJ, Rose DK, Goldstein MB. Influence of mannitol and dopamine on renal function during elective infrarenal aortic clamping in man. Am J Nephrol 1986;6:427-34.
34. Myles PS, Buckland MR, Schenk NJ, et al. Effect of "renal dose" dopamine on renal function following cardiac surgery. Anaesth Interns Care 1993;21:56-61.
35. Poison RJ, Park GR, Lindop MJ, Farman JV, Calne RY, Williams R. The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamine. Anaesthesia 1987;42:15-9.
36. Swygert TH, Roberts LC, Valek TR, et al. Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients. Anaesthesiology 1991;75:571-6.
37. Parks RW, Diamond T, McCrory DC, Johnston GW, Rowlands BJ. Prospective study of postoperative renal function in obstructive jaundice and the effect of perioperative dopamine. Br J Surg 1994;81:437-9.
38. Hall KA, Wong RW, Hunter GC, et al. Contrast-induced nephrotoxicity: The effects of vasodilator therapy. J Surg Res 1992;53:317-20.
39. Weisberg LS, Kurnik PB, Kurnik BRC. Dopamine and renal blood flow in radiocontrast induced nephropathy in humans. Renal Failure 1993;15:61-8.
40. Sandberg J, Tydén G, Groth CG. Low-dose dopamine infusion following cadaveric renal transplantation: no effect on the incidence of ATN. Transplant Proc 1992;24:357.
41. Whelan TV, Chidester PD, Higgins MR, Connito DJ, Yeh BPY. Effect of postoperative low dose dopamine infusion on early renal allograft function (abstract). J Am Soc Nephrol 1993;4:966.
42. DeLosAngeles A, Baquero A Bannett A, Raja R. Dopamine furosemide infusion for prevention of post transplant oliguric renal failure (abstract). Kidney Int 1985;27:339.
43. Kadieva VS, Friedman L, Margolius LP, Jackson SA, Morrell DF. The effect of dopamine on graft function in patients undergoing renal transplantation. Anesth Analg 1993;76: 362-5.
44. ter Wee PM, Smit AJ, Rosman JB, Sluiter WJ, Donker AJM. Effect of intravenous infusion of low dose dopamine on renal function in normal individuals and in patients with renal disease. Am J Nephrol 1986;6:42-6.
45. Conte G, Dal Canton A, Sabbatini M, et al. Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney Int 1989;36:1086-92.
46. Hansen JM, Olsen NV, Leyssac PP. Renal effects of amino acids and dopamine in renal transplant recipients treated with or without cyclosporine A. Clin Sci 1996;91:489-96.
47. Barnardo DE, Baldus WP, Maher FT. Effects of dopamine on renal function in patients with cirrhosis. Gastroenterobgy 1970;58:524-31
48. Davis RF, Lappas DG, Kirklin JK, Buckley MJ, Lowenstein E. Acute oliguria after cardiopulmonary bypass: renal functional improvement with low-dose dopamine infusion. Crit Care Med 1982;10:852-6.
49. Flancbaum L, Choban PS, Dasta JF. Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med 1994;22:61-6.
50. Henderson IS, Beattie TJ, Kennedy AC. Dopamine hydrochloride in oliguric states. Lancet 1980;2:827-8
51. Parker S, Carlon GC, Isaacs M, Rowland WS, Kahn RC. Dopamine administration in oliguria and oliguric renal failure. Crit Care Med 1981;9: 630-2.
52. Palmieri G, Morabito A, Lauria R et al. Low-dose dopamine induces early recovery of recombinant interleukin-2 impaired renal function. Eur J Cancer 1993;29A:1119-22.
53. Lindner A. Synergism of dopamine and furosemide in diuretic-resistant, oliguric acute renal failure. Nephron 1983;33:121-6.
54. Graziani G, Cantaluppi A, Casati S, et al. Dopamine and frusemide in oliguric acute renal failure. Nephron 1984;37:39-42.
55. Chertow GM, Sayegh MH, Allgren RL, Lazarus JM. Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Am J Med 1996;101:49-53
56. Lumlertgul D, Keoplung M, Sitprija V, Moollaor P, Suwangool P. Furosemide and dopamine in malarial acute renal failure. Nephron 1989;52: 40-4.
57. Olson LG, Hensley MJ, Saunders NA. Ventilatory responsiveness to hypercapnic hypoxia during dopamine infusion in humans. Am Rev Respir Dis 1982;126:783-7.
58. Green S, Smith J. Dopamine gangrene. N Engl J Med 1976;194:114.
59. Devins SS, Miller A, Herdon BL, O'Toole L, Reisz G. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med 1992;20:1644-9
60. Maynard ND, Bihari DJ, Dalton RN, Smithies MN, Mason RC. Increasing splanchnic blood flow in the critically ill. Chest 1995;108:1648-54.
61. Segal JM, Phang PT, Walley KR. Low-dose dopamine hastens onset of gut ischemia in a porcine model of hemorrhagic shock. J Appl Physiol 1992;73:1159-64.
62. Van den Berghe G, deZehger F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996;24:1580-90.
63. Fiddian Green RG. Studies in splanchnic ischaemia and multiple organ failure. In: Marston A, Bulkley GB, Fiddian-Green RG, et al eds. Splanchnic ischaemia and multiple organ failure. London: Edward Arnold, 1989; pp 349-63.
64. Zaritsky A, Lotze A, Stull R, Goldstein DS. Steady state dopamine clearance in critically ill infants and children. Crit Care Med 1988;16: 217-20.
65. Juste R, Moran L, Hooper J, Soni N. Dopamine clearance in critically ill patients, (abstract) Intensive Care Med 1997;23(suppl 2):S80.
66. Orme ML, Breckenridge A, Dollery CT. The effect of long term administration of dopamine on renal function in hypertensive patients. Eur J Clin Pharmacol 1973: 6: 150-5.
67. Cottee DBF. Con: dopamine does not preserve renal function. J Cardiothor Vasc Anesth 1995;9: 335-7.
68. McCrory C. Low dose dopamine: will there ever be a scientific rationale? Br J Anaesth 1997;78: 350-1.